MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
ACIU
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

AC Immune SA (ACIU) Earnings Date & Reports

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases... Show more

A.I. Advisor
published Earnings

ACIU is expected to report earnings to fall 8.32% to -17 cents per share on August 06

AC Immune SA ACIU Stock Earnings Reports
Q2'25
Est.
$-0.17
Q1'25
Beat
by $0.01
Q4'24
Beat
by $0.03
Q3'24
Beat
by $0.19
Q2'24
Missed
by $0.71
The last earnings report on April 30 showed earnings per share of -18 cents, beating the estimate of -20 cents. With 38.96K shares outstanding, the current market capitalization sits at 208.24M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ACIU
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View Trends For ACIU
(Try 14 days for Free)
Interact to see
Advertisement
A.I.Advisor
published price charts
AI Driven Trading
A.I. Advisor
published General Information

General Information

a developer of therapeutic and diagnostic products to prevent and modify diseases caused by misfolding proteins

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
EPFL Innovation Park
Phone
+41 213459121
Employees
161
Web
https://www.acimmune.com